Since the ROS/NF-κB pathway may be involved in the development of various diseases including immune system disorders, cardiovascular diseases and inflammatory diseases [17–21], we hypothesized that ZER may exert its anti-inflammatory effects through the ROS/NF-κB pathway. Here, NFKB1 is linked to cardiovascular disorder.